Time limited offer for new users ▶ Get up to 3 months free

Serving leading biopharmaceutical companies globally:

Last Updated: March 29, 2023

Drugs with Dosage: GEL

✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions

Drugs with Dosage: GEL

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration	Dosage
Padagis Israel	CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE	benzoyl peroxide; clindamycin phosphate	GEL;TOPICAL	205397-001	Sep 9, 2019	AB	RX	No	No	See Plans and Pricing	See Plans and Pricing				See Plans and Pricing	GEL;TOPICAL
Abbvie	ANDROGEL	testosterone	GEL;TRANSDERMAL	022309-002	Sep 7, 2012		DISCN	Yes	No	See Plans and Pricing	See Plans and Pricing	Y			See Plans and Pricing	GEL;TRANSDERMAL
Abbvie	ANDROGEL	testosterone	GEL;TRANSDERMAL	022309-002	Sep 7, 2012		DISCN	Yes	No	See Plans and Pricing	See Plans and Pricing				See Plans and Pricing	GEL;TRANSDERMAL
Abbvie	ANDROGEL	testosterone	GEL;TRANSDERMAL	022309-002	Sep 7, 2012		DISCN	Yes	No	See Plans and Pricing	See Plans and Pricing				See Plans and Pricing	GEL;TRANSDERMAL
Abbvie	ANDROGEL	testosterone	GEL;TRANSDERMAL	022309-002	Sep 7, 2012		DISCN	Yes	No	See Plans and Pricing	See Plans and Pricing	Y			See Plans and Pricing	GEL;TRANSDERMAL
Abbvie	ANDROGEL	testosterone	GEL;TRANSDERMAL	022309-002	Sep 7, 2012		DISCN	Yes	No	See Plans and Pricing	See Plans and Pricing	Y			See Plans and Pricing	GEL;TRANSDERMAL
Abbvie	ANDROGEL	testosterone	GEL;TRANSDERMAL	022309-002	Sep 7, 2012		DISCN	Yes	No	See Plans and Pricing	See Plans and Pricing				See Plans and Pricing	GEL;TRANSDERMAL
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration	>Dosage

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow

Baxter

Mallinckrodt

AstraZeneca

Boehringer Ingelheim

Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.